TransMedics Group, Inc. (BIT:1TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,010	2,021	2,331	1,844	468	442
Market Cap Growth	52.58%	-13.30%	26.45%	294.09%	5.88%	25.50%
Enterprise Value	4,056	2,203	2,411	1,716	408	362
PE Ratio	51.27	59.01	-	-	-	-
PS Ratio	8.31	4.74	10.67	21.08	17.58	21.08
PB Ratio	13.25	9.15	18.78	10.52	7.84	5.20
P/TBV Ratio	13.77	9.74	20.97	10.52	7.84	5.20
P/OCF Ratio	26.43	42.88	-	-	-	-
EV/Sales Ratio	8.33	5.17	11.03	19.62	15.34	17.25
EV/EBITDA Ratio	37.02	39.83	307.71	-	-	-
EV/EBIT Ratio	49.17	60.82	5495.72	-	-	-
Debt / Equity Ratio	1.46	2.27	3.76	0.36	0.65	0.33
Debt / EBITDA Ratio	4.07	8.19	38.35	-	-	-
Asset Turnover	0.65	0.59	0.49	0.45	0.21	0.20
Inventory Turnover	4.66	3.95	2.70	1.59	0.68	0.78
Quick Ratio	6.86	7.25	8.34	9.67	4.23	11.16
Current Ratio	7.69	8.30	9.30	10.66	5.11	12.36
Return on Equity (ROE)	32.48%	19.39%	-15.42%	-28.39%	-51.49%	-36.27%
Return on Assets (ROA)	6.93%	3.10%	0.06%	-9.54%	-17.18%	-12.82%
Return on Capital (ROIC)	7.48%	3.35%	0.07%	-10.72%	-19.70%	-14.51%
Return on Capital Employed (ROCE)	11.10%	5.00%	0.10%	-12.40%	-35.30%	-18.80%
Earnings Yield	1.95%	1.70%	-0.97%	-1.84%	-8.31%	-5.32%
FCF Yield	2.56%	-3.87%	-6.40%	-2.93%	-6.09%	-5.68%
Buyback Yield / Dilution	-13.12%	-8.30%	-10.02%	-7.02%	-11.80%	-73.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.